(CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into an agreement with Revitalist to participate in their Behavioral Health Network. This relationship will allow Revitalist to access many more patients to extend care for Behavioral Health. Furthermore, Revitalist is also pleased in announce a new COO Paul Auchterlonie.
Paul Auchterlonie brings three decades of experience in C-Suite leadership focused primarily in behavioral health. Mr. Auchterlonie earned his Master’s degree in adolescent development and administration from Harvard University. Additional skillsets include developing and implementing clinical solutions, technology oriented service models, admissions and marketing, disrupting fragmented services and verticals, building and improving company cultures, and leading entities towards value creation for all stakeholders. One of Mr. Auchterlonie’s passions is helping the adolescent population who is struggling immensely with mental health concerns, and exponential increase of suicides.
The vision that CEO, Kathryn Walker, has for this company is strategically aligned for every demand of the current mental health system. This model will be a global model that will be able to directly address the concerns that continue to plague the current mental health system. The agreement that we have entered into with CoreChoice is just the beginning to the payment restructuring that we will be actively addressing in 2023,” states Paul Auchterlonie.
Kathryn A. Walker is a pioneering medical researcher and psychiatrist known for her groundbreaking work in the field of mental health, particularly in the area of ketamine treatments. With a deep passion for understanding and alleviating the burden of treatment-resistant mood disorders, Kathryn has dedicated her career to investigating the therapeutic potential of ketamine.
Through her relentless efforts, she has played a pivotal role in shedding light on ketamine’s efficacy in treating conditions like depression, anxiety, and PTSD. Her research has not only transformed the way we approach mental health care but has also provided hope to countless individuals who had previously found little relief from conventional treatments.
Kathryn A. Walker’s pioneering contributions continue to shape the landscape of mental health medicine and inspire new avenues of research in the pursuit of better mental well-being for all.
